UNITED THERAPEUTICS Corp

UTHR

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001324863-26-000001
Filing date: Mar 5, 2026
Earliest execution date: Mar 4, 2026
Reporting Owners: Thompson Tommy G (Director)

Summary

Type

Sell

Net shares

-2,000

% of shares

-8.17%

Amount (USD)

$978,839

Insider confidence score

20.0 out of 100

Negative

  • Large discretionary sell (≥1% of shares)
  • Large sell amount ($250K+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Exercise

Date

2026-03-04

Code

M

Net shares

+2,000.0

Price per Share

$101.80

Amount (USD)

$203,600.00

Acquired/Disposed

Acquired

Shares Owned Before

8,480.0

Shares Owned After

10,480.0

Transaction 2

Security

Common Stock

Action

Sell

Date

2026-03-04

Code

S

Net shares

-2,000.0

Price per Share

$489.42

Amount (USD)

$978,839.40

Acquired/Disposed

Disposed

Shares Owned Before

10,480.0

Shares Owned After

8,480.0

Derivative Transactions

Transaction 1

Security

Stock Option

Action

Exercise

Date

2026-03-04

Code

M

Net shares

-2,000.0

Acquired/Disposed

Disposed

Shares Owned Before

4,000.0

Shares Owned After

2,000.0

Filing's footnotes

1. Includes 880 shares of common stock to be issued on or about July 8, 2026, as the result of the July 7, 2023 vesting of RSUs for which the reporting person elected to defer receipt of shares.

2. This transaction was executed in multiple trades at prices ranging from $488.95 to $489.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.